BPC-157 is notably stable in the gastric environment in preclinical models reportedly remaining intact in human gastric juice for extended periods which is one reason it has been studied so extensively in gut-related research
Injected Product Risks FDA identified concerns about product characterization, impurities, aggregates, endotoxins, immunogenicity, and the absence of human safety data
It is not ready to inject
A 2020 systematic review found that short-term use may have benefits, but long-term use can elevate fasting TMAO.28 From a prevention standpoint in relation to a number of chronic diseases, we are already encouraging people to decrease intake of red meat, Lampe says
A critical issue for future interventions is how to optimize the selectivity and targeting specificity of autophagy and ferroptosis modulation to pathological tissues while minimizing undesired deleterious consequences on normal tissues